Cargando…
Interferon is associated with improved survival for node-positive cutaneous melanoma: a single-institution experience
AIM: We assessed the role of adjuvant interferon on relapse-free survival (RFS), distant metastasis-free survival (DMFS) and overall survival (OS) in node-positive melanoma patients. METHODS: We retrospectively reviewed 385 node-positive patients without distant metastatic disease treated from 1998...
Autores principales: | Oliver, Daniel E, Sondak, Vernon K, Strom, Tobin, Zager, Jonathan S, Naghavi, Arash O, Sarnaik, Amod, Messina, Jane L, Caudell, Jimmy J, Trotti, Andy M, Torres-Roca, Javier F, Khushalani, Nikhil I, Harrison, Louis B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122528/ https://www.ncbi.nlm.nih.gov/pubmed/30190928 http://dx.doi.org/10.2217/mmt-2017-0025 |
Ejemplares similares
-
Re-biopsy of partially sampled thin melanoma impacts sentinel lymph node sampling as well as surgical margins
por: Weitman, Evan S, et al.
Publicado: (2019) -
Clinicopathologic Predictors of Survival in Patients with Desmoplastic Melanoma
por: Han, Dale, et al.
Publicado: (2015) -
Who Is to Blame for False-Negative Sentinel Node Biopsies in Melanoma?
por: Sondak, Vernon K., et al.
Publicado: (2009) -
Atypical Fibroxanthoma: Outcomes from a Large Single Institution Series
por: McClure, Erin, et al.
Publicado: (2023) -
Clinical results of combined vemurafenib and tumor-infiltrating lymphocyte therapy for metastatic melanoma
por: Sarnaik, Amod, et al.
Publicado: (2015)